Curcumin in Arthritis: Molecular Mechanisms, Preclinical Evidence, and Clinical Applications

Area of Science:

• Pharmacology and Molecular Biology
• Rheumatology
• Natural Product Therapeutics

Background:

• Arthritis involves complex inflammatory and degenerative processes.
• Curcumin, a compound from turmeric, has demonstrated potential anti-inflammatory and antioxidant properties.
• Understanding curcumin's multi-target effects is crucial for its therapeutic application in arthritis.

Purpose of the Study:

• To comprehensively evaluate the therapeutic potential of curcumin for arthritis.
• To analyze curcumin's molecular mechanisms, preclinical evidence, and clinical applications.
• To identify challenges and future research directions for curcumin in arthritis treatment.

Main Methods:

• Systematic literature search across major scientific databases.
• Inclusion of 165 studies covering molecular mechanisms, preclinical data, and clinical trials.
• Integrative evaluation of curcumin's effects on inflammatory, oxidative stress, and cell death pathways.

Main Results:

• Curcumin inhibits key inflammatory pathways (e.g., NF-κB) and reduces pro-inflammatory mediators (e.g., TNF-α, IL-1β).
• It modulates oxidative stress by enhancing antioxidant defenses (e.g., SOD, GSH) and regulates cell death pathways.
• Preclinical studies show anti-inflammatory, antioxidant, and chondroprotective effects; clinical data suggests pain and functional improvements in osteoarthritis, though limited.

Conclusions:

• Curcumin exhibits multi-target therapeutic potential for arthritis through its anti-inflammatory and antioxidant actions.
• Limited clinical evidence and bioavailability challenges necessitate further investigation.
• Large-scale randomized controlled trials with standardized, bioavailable formulations are required to validate curcumin's efficacy.